These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 15879134)

  • 1. Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.
    Padigel UM; Farrell JP
    J Immunol; 2005 May; 174(10):6340-5. PubMed ID: 15879134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
    Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G
    Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response.
    Muraille E; De Trez C; Brait M; De Baetselier P; Leo O; Carlier Y
    J Immunol; 2003 Apr; 170(8):4237-41. PubMed ID: 12682257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-TGF-beta treatment promotes rapid healing of Leishmania major infection in mice by enhancing in vivo nitric oxide production.
    Li J; Hunter CA; Farrell JP
    J Immunol; 1999 Jan; 162(2):974-9. PubMed ID: 9916722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phlebotomus papatasi sand fly salivary gland lysate down-regulates a Th1, but up-regulates a Th2, response in mice infected with Leishmania major.
    Mbow ML; Bleyenberg JA; Hall LR; Titus RG
    J Immunol; 1998 Nov; 161(10):5571-7. PubMed ID: 9820534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of IL-10 in promoting disease progression in leishmaniasis.
    Kane MM; Mosser DM
    J Immunol; 2001 Jan; 166(2):1141-7. PubMed ID: 11145695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease.
    Himmelrich H; Launois P; Maillard I; Biedermann T; Tacchini-Cottier F; Locksley RM; Röcken M; Louis JA
    J Immunol; 2000 May; 164(9):4819-25. PubMed ID: 10779790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Despite increased CD4+Foxp3+ cells within the infection site, BALB/c IL-4 receptor-deficient mice reveal CD4+Foxp3-negative T cells as a source of IL-10 in Leishmania major susceptibility.
    Nagase H; Jones KM; Anderson CF; Noben-Trauth N
    J Immunol; 2007 Aug; 179(4):2435-44. PubMed ID: 17675505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice.
    Anderson CF; Mendez S; Sacks DL
    J Immunol; 2005 Mar; 174(5):2934-41. PubMed ID: 15728505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The IL-4 rapidly produced in BALB/c mice after infection with Leishmania major down-regulates IL-12 receptor beta 2-chain expression on CD4+ T cells resulting in a state of unresponsiveness to IL-12.
    Himmelrich H; Parra-Lopez C; Tacchini-Cottier F; Louis JA; Launois P
    J Immunol; 1998 Dec; 161(11):6156-63. PubMed ID: 9834101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility to Leishmania major infection in interleukin-4-deficient mice.
    Noben-Trauth N; Kropf P; Müller I
    Science; 1996 Feb; 271(5251):987-90. PubMed ID: 8584936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-13 is a susceptibility factor for Leishmania major infection.
    Matthews DJ; Emson CL; McKenzie GJ; Jolin HE; Blackwell JM; McKenzie AN
    J Immunol; 2000 Feb; 164(3):1458-62. PubMed ID: 10640762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.
    Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F
    PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection.
    Jones DE; Buxbaum LU; Scott P
    J Immunol; 2000 Jul; 165(1):364-72. PubMed ID: 10861073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-leishmania effector functions of CD4+ Th1 cells and early events instructing Th2 cell development and susceptibility to Leishmania major in BALB/c mice.
    Louis JA; Conceiçao-Silva F; Himmelrich H; Tacchini-Cottier F; Launois P
    Adv Exp Med Biol; 1998; 452():53-60. PubMed ID: 9889959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
    Halliday A; Bates PA; Chance ML; Taylor MJ
    Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-9 is a susceptibility factor in Leishmania major infection by promoting detrimental Th2/type 2 responses.
    Arendse B; Van Snick J; Brombacher F
    J Immunol; 2005 Feb; 174(4):2205-11. PubMed ID: 15699153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Setting in motion the immune mechanisms underlying genetically determined resistance and susceptibility to infection with Leishmania major.
    Launois P; Conceiçao-Silva F; Himmerlich H; Parra-Lopez C; Tacchini-Cottier F; Louis JA
    Parasite Immunol; 1998 May; 20(5):223-30. PubMed ID: 9651923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines.
    Krishnan L; Guilbert LJ; Russell AS; Wegmann TG; Mosmann TR; Belosevic M
    J Immunol; 1996 Jan; 156(2):644-52. PubMed ID: 8543816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-12Rbeta2-deficient mice of a genetically resistant background are susceptible to Leishmania major infection and develop a parasite-specific Th2 immune response.
    Chakir H; Campos-Neto A; Mojibian M; Webb JR
    Microbes Infect; 2003 Apr; 5(4):241-9. PubMed ID: 12706437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.